Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies

NCT05262777 NA COMPLETED

A randomized, evaluator-blinded, parallel group, comparator-controlled, multicenter study to evaluate the safety and effectiveness of GP0112 for cheek augmentation and correction of midface contour deficiencies

Details

Lead sponsor	Galderma R&D
Phase	NA
Status	COMPLETED
Enrolment	211
Start date	Mon May 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Cheek Wrinkles
• Midface Contour Deficiencies

Interventions

• GP0112
• Restylane Lyft Lidocaine

Countries

Canada